These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 29885044)

  • 21. Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta-cell dysfunction.
    Yung B; Noormohamed FH; Kemp M; Hooper J; Lant AF; Hodson ME
    Diabet Med; 2002 Mar; 19(3):221-6. PubMed ID: 11963922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucose tolerance, insulin secretion, and insulin sensitivity in children and adolescents with cystic fibrosis and no prior history of diabetes.
    Elder DA; Wooldridge JL; Dolan LM; D'Alessio DA
    J Pediatr; 2007 Dec; 151(6):653-8. PubMed ID: 18035147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MARKEDLY DELAYED INSULIN SECRETION AND A HIGH RATE OF UNDETECTED OVERT DIABETES CHARACTERIZE GLUCOSE METABOLISM IN ADULT PATIENTS WITH CYSTIC FIBROSIS AFTER LUNG TRANSPLANTATION.
    Winhofer Y; Wolf P; Fellinger P; Tura A; Hillebrand P; Staufer K; Trauner M; Jaksch P; Muraközy G; Kautzky-Willer A; Pacini G; Krebs M; Luger A; Kazemi-Shirazi L
    Endocr Pract; 2019 Mar; 25(3):254-262. PubMed ID: 30913015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of insulin secretion indices in cystic fibrosis patients.
    Hammana I; Potvin S; Tardif A; Berthiaume Y; Coderre L; Rabasa-Lhoret R
    J Cyst Fibros; 2009 Dec; 8(6):378-81. PubMed ID: 19782008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peak glucose during an oral glucose tolerance test is associated with future diabetes risk in adults with cystic fibrosis.
    Bonhoure A; Potter KJ; Colomba J; Boudreau V; Bergeron C; Desjardins K; Carricart M; Tremblay F; Lavoie A; Rabasa-Lhoret R
    Diabetologia; 2021 Jun; 64(6):1332-1341. PubMed ID: 33693987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.
    Festa A; Williams K; Hanley AJ; Haffner SM
    Diabetes; 2008 Jun; 57(6):1638-44. PubMed ID: 18332099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural history of glucose intolerance in patients with cystic fibrosis: ten-year prospective observation program.
    Sterescu AE; Rhodes B; Jackson R; Dupuis A; Hanna A; Wilson DC; Tullis E; Pencharz PB
    J Pediatr; 2010 Apr; 156(4):613-7. PubMed ID: 19962154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disposition index identifies defective beta-cell function in cystic fibrosis subjects with normal glucose tolerance.
    Merjaneh L; He Q; Long Q; Phillips LS; Stecenko AA
    J Cyst Fibros; 2015 Jan; 14(1):135-41. PubMed ID: 24998161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral glucose tolerance test and continuous glucose monitoring to assess diabetes development in cystic fibrosis patients.
    Clemente León M; Bilbao Gassó L; Moreno-Galdó A; Campos Martorrell A; Gartner Tizzano S; Yeste Fernández D; Carrascosa Lezcano A
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Jan; 65(1):45-51. PubMed ID: 29137964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of GLP-1 and GIP on Islet Function in Glucose-Intolerant, Pancreatic-Insufficient Cystic Fibrosis.
    Nyirjesy SC; Peleckis AJ; Eiel JN; Gallagher K; Doliba A; Tami A; Flatt AJ; De Leon DD; Hadjiliadis D; Sheikh S; Stefanovski D; Gallop R; D'Alessio DA; Rubenstein RC; Kelly A; Rickels MR
    Diabetes; 2022 Oct; 71(10):2153-2165. PubMed ID: 35796669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Carbohydrate metabolic changes in cystic fibrosis].
    García-García E; López-Siguero JP; Olveira C; Pérez-Ruiz E; García JM; Pérez-Frías J; Martínez-Valverde A
    Med Clin (Barc); 1999 Nov; 113(16):601-3. PubMed ID: 10609251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin secretion abnormalities in exocrine pancreatic sufficient cystic fibrosis patients.
    Wooldridge JL; Szczesniak RD; Fenchel MC; Elder DA
    J Cyst Fibros; 2015 Nov; 14(6):792-7. PubMed ID: 25754095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of insulin secretory defects and insulin resistance during oral glucose tolerance test in a cohort of cystic fibrosis patients.
    Battezzati A; Mari A; Zazzeron L; Alicandro G; Claut L; Battezzati PM; Colombo C
    Eur J Endocrinol; 2011 Jul; 165(1):69-76. PubMed ID: 21502328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship between insulin secretion, the insulin-like growth factor axis and growth in children with cystic fibrosis.
    Ripa P; Robertson I; Cowley D; Harris M; Masters IB; Cotterill AM
    Clin Endocrinol (Oxf); 2002 Mar; 56(3):383-9. PubMed ID: 11940051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patients with cystic fibrosis and normoglycemia exhibit diabetic glucose tolerance during pulmonary exacerbation.
    Sc NN; Shoseyov D; Kerem E; Zangen DH
    J Cyst Fibros; 2010 May; 9(3):199-204. PubMed ID: 20188638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Islet Hormone and Incretin Secretion in Cystic Fibrosis after Four Months of Ivacaftor Therapy.
    Kelly A; De Leon DD; Sheikh S; Camburn D; Kubrak C; Peleckis AJ; Stefanovski D; Hadjiliadis D; Rickels MR; Rubenstein RC
    Am J Respir Crit Care Med; 2019 Feb; 199(3):342-351. PubMed ID: 30130412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous glucose monitoring in cystic fibrosis patients according to the glucose tolerance.
    Moreau F; Weiller MA; Rosner V; Weiss L; Hasselmann M; Pinget M; Kessler R; Kessler L
    Horm Metab Res; 2008 Jul; 40(7):502-6. PubMed ID: 18415892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis].
    Khammar A; Stremler N; Dubus JC; Gross G; Sarles J; Reynaud R
    Arch Pediatr; 2009 Dec; 16(12):1540-6. PubMed ID: 19854630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations Between Glucose Tolerance, Insulin Secretion, Muscle and Fat Mass in Cystic Fibrosis.
    Nielsen BU; Faurholt-Jepsen D; Oturai PS; Qvist T; Krogh-Madsen R; Katzenstein TL; Shaw J; Ritz C; Pressler T; Almdal TP; Mathiesen IHM
    Clin Med Insights Endocrinol Diabetes; 2021; 14():11795514211038259. PubMed ID: 34413690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevation of 1-hour plasma glucose during oral glucose tolerance testing is associated with worse pulmonary function in cystic fibrosis.
    Brodsky J; Dougherty S; Makani R; Rubenstein RC; Kelly A
    Diabetes Care; 2011 Feb; 34(2):292-5. PubMed ID: 21228248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.